Search Results
Displaying 21 - 30 of 1056
… On this page What is benign essential blepharospasm? Benign Essential … to as many people as possible, and that treatments will be safe and effective for everyone who will use them. For … clinical research visit NIH Clinical Research Trials and You . Learn about clinical trials currently looking for …
… ataxias? Spinocerebellar ataxias (SCA) refer to a group of rare, genetic neurological disorders that cause loss of muscle control, coordination, and balance. The SCAs involve … generation, especially when passed from the male parent. How are spinocerebellar ataxias diagnosed and treated? …
… syndrome? Coffin-Lowry syndrome is a rare genetic disorder characterized by craniofacial (head and facial) and … trials are studies that allow us to learn more about disorders and improve care. They can help connect patients … can learn more about the Coffin-Lowry syndrome and related disorders. Clinical research uses human volunteers to help …
… In October 1983, the U.S. Congress established the Senator Jacob Javits Awards … research in a wide variety of disorders of the brain and nervous system. The Javits Award (R37) is a conditional, seven-year research grant given to …
… many causes, including genetic variations, illness, head injury, or abnormal brain development. NIH / NINDS and its … use studies of animals and patients with traumatic brain injury (TBI) leading to post-traumatic epilepsy (PTE) in … and Its Progression Epilepsy Benchmarks Area III: Improved Treatment Options for Controlling Seizures and …
Program DescriptionThe mission of the NINDS Division of Clinical Research is to provide oversight for clinical trials to test the safety and efficacy of innovative treatments of neurological disorders and stroke, epidemiological…
Tuesday, October 31, 2023
By Walter J. Koroshetz, M.D., Director, NINDS, Amir Tamiz, Ph.D., Director of the Division of Translational Research at NINDS, and Emily Caporello, Ph.D., Program Director, NINDS Small Business Program
NINDS-funded science is the foundation that supports the development of new diagnostics and treatments for neurological disorders. However, advancing a therapeutic molecule or device from the laboratory to adoption by industry and then dissemination into healthcare is challenging and…
… other neurological disorders might, such as Parkinson’s, epilepsy, or stroke. While NINDS devotes ample efforts toward … therapies for the more than 70% of rare diseases with genetic causes. (Please be sure to read NINDS Deputy … strategies for gene-targeted therapies for patients with neurological/neuromuscular disorders, including rare …
… is an inherited neuromuscular disorder characterized by the inability of muscles to quickly relax after a voluntary contraction. …